Rhenman & Partners Asset Management Ab Ionis Pharmaceuticals Inc Transaction History
Rhenman & Partners Asset Management Ab
- $1.2 Billion
- Q3 2024
A detailed history of Rhenman & Partners Asset Management Ab transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 195,000 shares of IONS stock, worth $6.63 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
195,000
Previous 130,000
50.0%
Holding current value
$6.63 Million
Previous $6.2 Million
26.09%
% of portfolio
0.65%
Previous 0.61%
Shares
5 transactions
Others Institutions Holding IONS
# of Institutions
402Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$512 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$482 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$351 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$297 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$268 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.83B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...